The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 11, 2023
Multiply Labs, a robotics company developing automated manufacturing systems to produce individualized drugs (including but not limited to cell ...
read more
Thermo Fisher Scientific announced it has expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from ...
read more
Thursday, October 05, 2023
Lonza announced an extension of a long-term collaboration with a major global biopharmaceutical partner.
read more
Wednesday, September 27, 2023
Theradaptive, a biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a U.S. Department of Defense (...
read more
Thursday, September 21, 2023
The FDA granted Orphan Drug Designation (ODD) designation for NXC-201 for the treatment of a life-threatening blood disorder, Amyloid Light Chain (AL)...
read more
Wednesday, September 20, 2023
Alexion, AstraZeneca Rare Disease, has completed a definitive purchase and license agreement for a portfolio of preclinical rare disease gene therapy ...
read more
Tuesday, September 19, 2023
Nexcella, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other ...
read more
Tuesday, September 19, 2023
ALSA Ventures, a UK-based, therapeutics-focused venture capital fund, announced the acquisition of Axovia Therapeutics Inc and the launch of a new ...
read more
Thursday, September 07, 2023
Eminence Biotechnology’s state-of-the-art facility for the commercial production of cell culture media is now fully operational.
read more
Tuesday, September 05, 2023
SomaLogic, Inc., a provider of proteomics technology, announced that it is extending its collaborative agreement with Novo Nordisk.
read more
Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their 'Human T Cell ...
read more
Cellares, an first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing,...
read more
Bruker Corporation signed a definitive agreement to acquire PhenomeX for $1.00 per share in an all-cash transaction.
read more
Astellas Pharma and Poseida Therapeutics announced an investment to support Poseida's commitment to redefining cancer cell therapy.
read more
Wednesday, August 02, 2023
Kala Pharmaceuticals announced that it will change its name to KALA BIO, effective August 2, 2023,
read more